InsidersTradesSigma
한독 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 한독 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 한독 has recorded 26 public disclosures. The latest transaction was disclosed on 18 June 2026 (Other). Among the most active insiders: 김영진. All data is free.
26
Insider Decl.
n/a
Thresholds
€282,242
6 ops.
Buy Volume
n/a
1 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 18 June 2026
Declarations26 total
56,676 shares@ ₩8,800.00100.0% of flowShareKRXDART:20260604000304
25 of 26 declarations
About 한독
HanDoc is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.